| Item number | Description |
|---|---|
| 8667-20 | SynchroMed™ III pump with 20 mL reservoir capacities, redesigned with updated electronics and firmware to enhance cybersecurity and enable upgradability |
| 8667-40 | SynchroMed™ III pump with 40 mL reservoir capacities, redesigned with updated electronics and firmware to enhance cybersecurity and enable upgradability |
| CT900 | Tablet with A810 software v2.x, SynchroMed™ clinician programmer with refill-only workflow that streamlines clinician programming |
| TH90T02 | Handset with communicator kit |
Drug infusion systems
SynchroMed™ III intrathecal pump
<p>SynchroMed™ III is an implantable drug delivery system that helps manage chronic pain, cancer pain, and severe spasticity.</p>
Features
SynchroMed™ III pump
This system features a refill only physician workflow for more efficient programming, additional protections for patient data through enhanced cybersecurity, and improved electronics capable of delivering firmware upgrades to implanted devices going forward.
Together, these enhancements within the SynchroMed™ III system offer an enhanced platform compared to use of the SynchroMed™ II system.
Allows full-body 1.5 and 3T MRI† scans under specific conditions
Redesigned for peace of mind
The SynchroMed™ III implantable pump continues to provide peace of mind with proven durable design enhancements built in.‡
2011
Battery coating added
2015
Gear wheel 3 material change
2015
Feedthroughs encapsulated
2017
Diamond-like carbon (DLC) coating added
Ascenda™ intrathecal catheter
- Available in two lengths
- Flexible construction with the ability to trim to the desired length
- Unique four-layer construction for compression resistance
- Sutureless connector
Compatible products
SynchroMed™ clinician programmer
The SynchroMed™ clinician programmer provides a simple, guided workflow approach to programming SynchroMed™ implantable pumps.
myPTM™ application
The myPTM™ personal therapy manager works with the SynchroMed™ implantable pump to help alleviate unpredictable pain by enabling on-demand intrathecal boluses.
Ordering information
Resources
†
Under specific conditions. Refer to product labeling for full list of conditions: Medtronic MRI manuals.
‡ Source: TDD Product Performance Report 2022.
- Hamza, M et al. Prospective Study of 3-Year Follow-Up of Low-Dose Intrathecal Opioids in the Management of Chronic Nonmalignant Pain. Pain Medicine. (United States) 13, 1304–1313 (2012).
- Smith, TJ et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. Journal of Clinical Oncology. 20, 4040–4049 (2002).
- Rushton, DN. Upper Motor Neurone Syndrome and Spasticity: Chapter 10 Intrathecal Baclofen for the Control of Spinal and Supraspinal Spasticity. ed. Barnes, MP and Johnson, GR pages 181–192. (Cambridge University Press, 2008). doi:10.1017/cbo9780511544866.011.
- Deer, T et al. Intrathecal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain. Pain Medicine. 5, 6–13 (2004).
This product is licenced with Health Canada as SYNCHROMED III on Health Canada licence number 112006.